GSK reaches $2.2bn heartburn medication Zantac settlement in US
WEB15 hours ago · GSK has reached a $2.2bn settlement to resolve the vast majority of cases linked to its heartburn medicine Zantac, in a move that will help assuage legal concerns overhanging the UK drugmaker. The ...
GSK reaches up to $2.2 billion settlement in Zantac US state court …
WEB16 hours ago · GSK said on Wednesday it had reached agreements with ten plaintiff firms, representing 93% of U.S. state court Zantac product liability cases pending against the drugmaker, for up to $2.2 billion.
FDA Requests Removal of All Ranitidine Products (Zantac) from …
WEBThe U.S. Food and Drug Administration today announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. This is the ...
GSK to Settle 80,000 Zantac Cases for Up to $2.2 Billion
WEB16 hours ago · Translate. GSK Plc said it will pay as much as $2.2 billion to resolve about 80,000 US court cases related to contamination of its Zantac reflux medication with a suspected carcinogen. The cases ...
Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts
WEBApr 5, 2024 · Zantac heartburn pills are seen in this picture illustration taken October 1, 2019. Sanofi has reached an agreement in principle to settle 4,000 US lawsuits linking the discontinued heartburn drug ...
GSK shares tumble after Delaware court ruling on Zantac - Financial Times
WEBJun 3, 2024 · GSK and the other drugmakers that sold Zantac dispute these claims. The London-listed group said it planned to appeal against the Delaware ruling. Shares in GSK were down 9.5 per cent on Monday ...
Drugmakers' appeal to end Zantac cancer lawsuits rebuffed by …
WEBJul 1, 2024 · First approved in 1983, Zantac became the world's best-selling medicine in 1988 and one of the first to top $1 billion in annual sales. It was originally marketed by a forerunner of GSK and later ...
Delaware top court will hear drugmakers' appeal to end Zantac …
WEBAug 27, 2024 · Delaware's highest court said on Tuesday it will hear an appeal by GSK and other drugmakers seeking to end more than 70,000 lawsuits claiming discontinued heartburn drug Zantac caused cancer.
GSK set to face jury trials over heartburn drug Zantac - Financial Times
WEBJun 1, 2024 · Companies linked to the drug lost a combined $40bn in value in days. GSK, Sanofi and Pfizer have sought to settle numerous cases relating to Zantac. Last month Pfizer offered up to $250mn to ...
Delaware judge lets more than 70,000 Zantac lawsuits go forward
WEBJun 1, 2024 · A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.